{
}
AXA, Europe's leading insurance group, reports a sales breakdown of 62.7% from property-casualty insurance, which includes motor, home, and liability coverage, alongside assistance services. Life insurance accounts for 35.9% of sales, offering savings and health policies, while other activities, primarily banking, contribute 1.4%.
UBS has rated Schneider Electric as a 'Buy', but the information provided is for informational purposes only and does not constitute a recommendation to buy or sell. Investing in securities carries risks, including the potential total loss of capital, and does not replace tailored expert investment advice. No liability for the accuracy or completeness of the information is assumed.
UBS has upgraded Schneider Electric to a "Buy" rating with a target price of 290 euros, citing expectations of solid quarterly results at the end of April. Analyst Andre Kukhnin believes the current lower share price presents an attractive entry opportunity, with no anticipated changes to the company's 2025 organic sales and margin targets.
UBS has reduced its price target for Pernod Ricard from 114 to 101 euros while maintaining a "Neutral" rating. Analyst Sanjeet Aujla anticipates another weak quarter for the spirits producer, citing risks to organic sales expectations and lowering forecasts for sales and earnings.
UBS has raised its target price for Safran, as reported by Cercle Finance and published by BOURSORAMA. The analysis is provided for informational purposes only, with BOURSORAMA acting solely as a distribution channel and not responsible for the content or any potential conflicts of interest.
UBS has raised its target price for Safran from 235 to 265 euros while maintaining a 'neutral' recommendation, indicating an 8% upside potential. The broker notes that approximately 20% of Safran's sales are defense-related, positioning the company to benefit from the ongoing defense supercycle.
UBS has downgraded its recommendation for Scor from Buy to Neutral, maintaining a price target of 28.70 euros. The firm cites concerns over the company's high gearing compared to peers, disappointing organic capital generation, and the quality of its Solvency II ratio, which limit the potential for a higher payout ratio despite a 7.2% dividend yield.
UBS has downgraded Scor from Buy to Neutral, maintaining a target price of €28.70, citing limitations on dividend payouts due to high gearing, weak capital generation, and Solvency II ratio quality. The reinsurer, the fifth-largest globally, focuses on life and health, property & casualty, and investments, with a commitment to innovation and environmental sustainability. Challenges include sensitivity to natural catastrophes and currency fluctuations, alongside ongoing arbitration regarding the US life portfolio sale to Covea.
UBS has downgraded its recommendation on Scor from 'buy' to 'neutral', while keeping the target price at €28.7, indicating only a 4% upside potential for the shares. The downgrade is attributed to concerns over debt leverage, capital generation, and solvency quality, which limit the company's growth prospects.
Scor SE, France's leading reinsurer, has been downgraded from "buy" to "neutral" by UBS. The company's gross written premiums are divided into life and health reinsurance (50.8%) and non-life reinsurance (49.2%), which includes property and casualty as well as specialty reinsurance. Geographically, premiums are distributed with 12.6% from France, 45.9% from Europe, 23.8% from the Far East, and smaller percentages from North America, South America, Africa, and others.
FRA
Country
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
axa reports strong sales in property casualty and life insurance sectors
11:46 31.03.2025
ubs rates schneider electric as buy amid investment considerations and risks
11:05 31.03.2025
ubs upgrades schneider electric to buy with target price of 290 euros
11:05 31.03.2025
UBS lowers Pernod Ricard price target amid weak sales outlook
10:54 31.03.2025
ubs raises target price for safran in recent analysis
10:42 31.03.2025
ubs raises safran target price amid defense market optimism
10:42 31.03.2025
ubs downgrades scor to neutral citing dividend yield and capital concerns
10:31 31.03.2025
ubs downgrades scor to neutral amid concerns over dividend yield and capital generation
10:30 31.03.2025
ubs downgrades scor to neutral citing limited upside potential and risks
10:28 31.03.2025
scor downgraded to neutral by ubs amid premium breakdown analysis
10:27 31.03.2025
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Global Trade Developments
Global Financial Events
Central Bank Actions
Banking Regulations
Retail and Consumer Goods
Startups & Entrepreneurship
Finance Mergers & Acquisitions
Government Economic Policies
Inflation and Monetary Impact
Industry Mergers & Acquisitions
CEO Changes
Domestic Politics
Market Analysis and Predictions
Government Policies
Workplace Trends
GDP Growth & Recession Forecasts
Supply Chain Management
Countries:
Companies:
Tesla, Inc.
Apple Inc.
Barclays PLC
JPMorgan Chase & Co.
Deutsche Bank Money Market PP
Credit Suisse Strategic Income I
The Goldman Sachs Group, Inc.
SpaceXCoin USD
Berkshire Hathaway Inc.
Bank of America Corporation
UBS Group AG
BNP Paribas SA
Banco Santander, S.A.
Lloyds Banking Group plc
Bank Frick AG
Morgan Stanley
NVIDIA Corporation
Jenoptik AG
Air France-KLM
Citigroup Inc.
Currencies:
United States Dollar
Euro
Swiss Franc
Japanese Yen
British Pound Sterling
Indian Rupee
Chinese Yuan
South Korean Won
Canadian Dollar
Vietnamese Đồng
Australian Dollar
Thai Baht
Indonesian Rupiah
Singapore Dollar
Mexican Peso
Hong Kong Dollar
Offshore Chinese Yuan
New Zealand Dollar
Cambodian Riel
Myanmar Kyat
People: